ABSTRACT; The objectives were to examine in vitro fermentation characteristics, in vivo nutri ent digestibility, fecal microbiota, and serum lipid profiles as affected by a-cyclodextrin (ACD) supple mentation, Short-chain fatty acid (SCFA) production was measured after in vitro fermentation for 3, 6, 9, and 12 h ofACD, p-cyclodextrin, and y-cyclodextrin.
INTRODUCTION
According to the American Association of Cereal Chemists (2001) , dietary fibers promote beneficial physiological effects including laxation, blood choles terol attenuation, and/or blood glucose attenuation. The blood cholesterol attenuation effect has been proven for some soluble fibers including psyllium, p-glucan, pectin, and guar gum (Bazzano, 2008) . This physio logical effect is important because hyperlipidemia has been clearly linked to the risk ofcardiovascular disease and obesity. More specifically, high low-density lipo-'Conflictsof interest: M.A.G., L.L.B.,G.C.F. Jr.,and M.R.C.G. declare that they have no conflict of interest to disclose. K.A.G. is employed by Abbott Nutrition. doi:10.2527/jas2015-9925 protein cholesterol concentrations in serum may ac count for a large proportion ofcardiovascular disease case in western cultures (Bruckert and Rosenbaum, 2011) . Similar to humans, obese dogs also suffer from hyperlipidemia, even though they are less susceptible to cardiovascular disease (Xenoulis and Steiner, 2010) .
Cyclodextrins are capable of forming complexes with apolar substances such as cholesterol (Szejtli, 2004) , thus blocking its absorption. It has been report ed that intakeofa-cyclodextrin (ACD), p-cyclodextrin (BCD), and y-cyclodextrin (GCD) can result in a 15 to 20% decrease in serum total cholesterol (TC) concen trations (Favier et al., 1995; Kaewprasert et al., 2001) . Cyclodextrin intake by rats has been reported to re sult in a 60% increase in the weight of cecal tissues, over a 2-fold increase in weight ofcecal contents, and over a 3-fold increase in total short-chain fatty acid (SCFA) concentrations. At the same time, it has been reported that BCD intake enhances (1.8-fold) bile acid excretion (Levrat et al., 1994) . Consequently, the hypocholesterolemic effect of cyclodextrins appears to be mediated, at least partially, by changes in fermentation patterns in the large intestine.
Studying the effects of ACD supplementation on ileal nutrient digestibilities, fermentation pattems, and gastrointestinal microbiota will help determine the mechanism of ACD action as regards cholesterol me tabolism. The objectives of this study were to examine in vitro fermentation characteristics, in vivo nutrient di gestibility, fecal microbiota responses, and serum lipid profiles of dogs as affected by ACD supplementation.
MATERIALS AND METHODS

Samples
Commercial food-grade ACD (purity 99.4%) manufactured by Wacker Fine Chemicals (Adrian, MI; batch number 60F212) was obtained from Abbott Nutrition (Columbus, OH). Carbohydrates used dur ing the in vitro experiment also included commercial food-grade BCD and CCD (Wacker Fine Chemicals).
In Vitro Fermentation Experiment
Donors and Collection Method, Three human fecal samples from 3 individual malevolunteers were pooled to serve as the source ofinoculum. All donors consumed their normal diet, were greater than 18 yr old, were free of gastrointestinal disease, and had not received an tibiotics at least 3 mo before or during the study. The experimental protocol was approved by the University of Illinois Institutional Review Board, and all subjects signed an informed consent before initiation of the ex periment.On the morning ofthe experiment,each donor provided a fresh fecal sample (within 15 min ofdefeca tion) collected using a Commode Specimen Collection System (Sage Products, Crystal Lake, IL).
Substrates. Approximately 500 mg ofACD, BCD, or GCD were placed in tubes in triplicate for in vitro fermentation measurements.
Procedure. On the experiment day, fecal samples from donors were received and maintained at 37°C until inoculum was prepared. Anaerobic inoculum was prepared from fresh fecal samples within 15 min of defecation. Equal amounts of feces from each do nor were mixed together and diluted 1:10 (wt/vol) in anaerobic dilution solution (Bryant and Burkey, 1953) by blending for 15 sec in a Waring blender (Waring Laboratory Science, Global Resources, Inc., Winsted, CT) under a stream of CO2 Blended, diluted feces were filtered through 4 layers of cheesecloth and sealed in 125-mL serum bottles under CO2. '1 g/L resazurin indistilled H2O.
Each substrate was fermented in vitro for 0, 3, 6, 9, and 12 h in triplicate with microbial inoculum. Triplicate tubes containing no substrate were ferment ed with the inoculum at each time point to enable ap propriate corrections for SCFAproduction not arising from the substrates. A semidefined medium was used for the fermentation (Table 1 ). All components except for the vitamin solutions were mixed before autoclave sterilization of the medium. Filter-sterilized vitamin solutions were added just before dispensing the me dium, which was maintained under anaerobic condi tions at all times after preparation. Aliquots (26 mL) of medium wereaseptically trans ferred to 50-mL centrifuge tubes and capped with rub ber stoppers with 1-way Bunsen valves. All tubes were storedat 4®C for approximately 12h to enablehydration of the substrates before initiating fermentation. Tubes were placedin a 37°C waterbath approximately 30 min before inoculation. Diluted feces (4 mL) were inoculat ed into tubes containing either only 26 mL semidefined medium (blank tubes) or 26 mL semidefmed medium and substrate. Tubes were incubated at 37°C with pe riodic mixing for the respective fermentation times. At the appropriate time,tubeswere removed fromthe 37°C incubator and immediately processed for analyses. The pH of tube contents was measured with a standard pH meter (Denver Instrument Co., Arvada, CO).
A 2.0-mL subsample was taken from each tube for SCFA analyses. Samples to be analyzed for SCFA were mixed with 0.5 mL of 250 g/L m-phosphoric acid, precipitated at room temperature for 30 min, and then centrifliged at 20,100 x g at 4°C for 20 min. The supematant was decanted and frozen at -20°C in microcentrifuge tubes. After freezing, the supernatant was thawed and centrifliged in microcentriflige tubes at 16,000 X g at 20®C for 10 min. The supernatant then was transferredto gas chromatography vials and stored at -20°C until analysis.
Chemical Analyses. Concentrations of SCFA were determined using GLC (Erwin et al., 1961) . Briefly, concentrations of acetate, propionate, and butyrate were determined in the supernatant ofthe tubes using a Hewlett-Packard 5890A Series 11 gas-liquid chromatograph (Agilent, Santa Clara, CA) and a glass column (180 cm by 64 mm i.d.) packed with 10% SP-1200/1% H3PO4 on 80/100 mesh Chromosorb WAW (Supelco Inc., Bellefonte, PA). Short-chain fatty acid concentrations were corrected for the quantities of SCFA produced in the blank tubes.
Statistical Analysis. Data for SCFA production were fitted to a logistic model equation to determine the rate of production and the time to attain maximal rate of production for each:
in which Y = SCFA production; A = asymptote, or maximal SCFA production expressed in micromoles per gram DM; t = incubation time in hours; C = time in hours at which the rate ofSCFA production is maxi mum (the inflection point); and 5 = a measure of the duration of SCFA production in hours.
Variables are reported and were compared using preplanned contrasts and estimates. Standard error of the mean values are associated with least squares means as cal culated in the Mixed Models procedure. Contrasts with a P-value of less than 0.05 were considered sig nificant, and P-values greaterthan 0.05 but less than or equal to 0.10 were consideredtrends.
Heal and Total Tract Nutrient Digestibility
Animals. Five female purpose-bred hound-mix dogs with an average age of 5.4 yr (3 to 8 yr) and an average initial BW of 23.1 kg (SD 2.5) were used in this experiment. Dogs previously had been surgically prepared with a T-shaped cannula proximal to the 11-eocecal junction according the procedure of Walker et al. (1994) . The University of Illinois Institutional Animal Care and Use Committee approved all ani mal care procedures before initiation of the experi ment. Dogs were individually housed in indoor pens (approximately 1.2 by 1.5 m) in an environmentally controlled facility (22°C and 23% relative humidity) with a 16:8 h light:dark cycle. Dogs were weighed and BCS was assessed using a l-to-9 scale (Laflamme, 1997) 4 g of ACD diluted in 15 mL of water twice per day for a total of0,2,4,6, and 8 g ACD/d. Experimental Design. The experimental design was a 5 X5 Latin square design. Each period consisted of 2 phases: 10 d for diet adaptation and 4 d for fe cal collection. Dogs were weighed, BCS was assessed, and blood was collected at the beginning and at the end ofeach period after a 12-h fast.
Sampling Procedures. Asample ofapproximately 500 g was taken from each bag of diet used in this ex periment. Samples were composited, and a 500-g subsample was removed, ground in a Wiley mill (model 4; Thomas Scientific, Swedesboro, NJ) through a 2-mm screen, and stored at 4®C until further analyses. During the 4-d collection phase, all voided feces were collected from the floor of the pen and weighed. Feces were scored on a 5-point scale, with 1 being dry, hardpellets; 2 beingdry, well-formed stool;3 beingsoft, moist, formed stool; 4 being unformed stool; and 5 be ing watery, liquid that can be poured. Feces were stored at -20°C until composited and ground for analysis. On d 14 ofeach period, fresh fecal samples, aliquoted only from the interior part of the stools, werecollected with in 15 min of defecation, flash frozen in liquid nitrogen, and stored at -80°C for bacterial analyses. A short time between defecation and sampling (i.e., 15 min) is im portant for microbial analysis to minimize DNAdam age and obtainhigh-quality DNAfor sequencing.
Heal effluent was collected 3 times/d over 4 d, with an interval of 4 h between the start of collections and with individual ileal collections lasting 1 h. Heal col lection times were adjusted by 1 h from the previous day's collection time for a total of 12 samples per ani mal per 4-d collection period. Heal effluent was col lected into a sterile sampling bag by attaching the bag to the cannula extension with a rubber band. Before bag attachment, cannula barrels were scraped clean using a spatula. During collections, dogs wore BiteNot collars (Bite-Not Products, San Francisco, CA) to prevent the dog from removing the sample bag. Dogs were encouraged to move freely during collections. After collection, a cannula plug was placed in the bar rel and the cannula site was cleaned with a dilute betadine solution. Heal samples were frozen at -20®C in their individual bags until further analyses. After all samples were collected, ileal effluent from each dog was composited by period and refrozen at -20°C.
Before d 1 and after d 14 of each period, 5 mL of blood were collected via jugular venipuncture. At 1900 h on the evening before each blood sampling, any remaining food was removed, and dogs were fasted overnight (12 h), during which time they consumed only water. Because periods were consecutive, blood metabolite concentrations at the end of one period were used as baseline values for the start of the next period. Blood was drawn into vacutainer serum sepa rator tubes before feeding the dogs. Tubes were kept at room temperature for 30 min and centrifuged at 1,240 Xg at 4°C for 10 min. Serum was collected and stored at -20°C for analyses.
ChemicalAnalyses. Frozen feces were placed in a forced-air oven at 55°C until a constant moisture level in the samples was achieved. Heal effluent was lyophilized in a Dura-Diy MP microprocessor-controlled ffeezedryer (FTS Systems, Stone Ridge, NY). Once diy, ileal effluent was ground with a mortar and pestle. Diet and dried fecal samples were ground in a Wiley mill (mod el 4; Thomas Scientific) through a 2-mm screen.
DrymatterandCM concentrations weredetermined according to AGAC International (Horwitz, 2002) methods 934.01 and 942.05, respectively. Acid hydrolyzed fat (AHF) concentrations were determined using acid hydrolysis according to American Association of Cereal Chemists (2000) method 30-14.01 followed by ether extraction (Budde, 1952) . Crude protein concen trations were determined using LECO nitrogen values (N X6.25; method 992.15; Horwitz, 2002 ; nitrogen an alyzer model FP-2000; Leco Corporation, St. Joseph, MI). Total dietary fiber concentration of the diet was measured according to Prosky et al. (1985) . Gross en ergy concentrations of ACD and diet were measured using an oxygen bomb calorimeter (model 1261; PanInstruments, Moline, IL). Food, ileal, and fecal sam ples were prepared for chromium analysis according to the method ofWilliams et al. (1962) , and chromium concentrations were measured using an atomic absorp tion spectrophotometer (model 3100; PerkinElmer, Calculations. Apparent total tract DM digestibilities were calculated as 100 -(100 x marker concentration in the feed (%)/marker concentration in the feces (%)). Apparent total tract nutrient digestibilities were calculat ed as 100 -100(marker concentration in the feed (%) x nutrient concentration in feces (%)/(marker concentra tion in feces (%) x nutrientconcentrationin the feed (%)). Apparent ileal DM digestibilities were calculatedas 100-(100 Xmarker concentration in the feed (%)/marker concentration in the ileal effluent (%)). Apparent ileal nu trient digestibilities were calculated as 100-100(marker concentration in the feed (%) x nutrient concentration in ileal effluent (%)/marker concentration in ileal effluent (%) Xnutrient concentration in the feed (%)).
Microbiota Quantification. Microbiota popula tions were quantified using molecular techniques. Bacterial DNA in feces was extracted and purified from frozen samples using QlAamp DNA stool mini kits (Qiagen, Valencia, CA) using the repeated bead beating plus column method described by Yu and Morrison (2004) . Fecal DNA was quantified using a NanoDrop ND-1000 spectrophotometer (NanoDrop Technologies, Wilmington, DE). Escherichia coll, Clostridium perfringens, bifidobacteria, and lactobacilli were quantified via quantitative PGR (qPCR) analysis using specific primers (Middelbos et al., 2007) . Amplification was performed on a set of trip licate reactions for each bacterial group within each sample according to the procedures previously de scribed by Hemot et al. (2009) .
StatisticalAnalyses. Data were analyzed as a Latin square design using the Mixed procedure ofSAS/STAT software, version 9.2 for Windows. The statistical mod el included the fixed effect ofdietary treatment and the random effects of period and dog. Normal distribution of residuals and homogeneity of variances were tested, and assumptions for ANOVA were fulfilled. It was as sumed that there was no interaction between period and treatment, period and dog, and treatment and dog. Treatment least squares means are reported and were compared using preplanned orthogonal polynomial contrasts. Linear and quadratic effects of ACD supple mentation were analyzed. Standard error of the mean values are associated with least squares means as cal culatedin the MixedModelsprocedure. Contrasts with a P-value of less than 0.05 were considered significant, and P-values greaterthan 0.05 but less than or equal to 0.10 were considered trends.
RESULTS
In Vitro Fermentation Experiment
Short-chain fatty acid production profiles result ing from fermentation of cyclodextrins are presented in Table 3 . Maximal production oftotal SCFAwas greatest (P < 0.05) for BCD followed by GCD and ACD (values did not statistically differ). However, the maximal rate of production was numerically greatest for GCD, which also attained maximal rate of production most rapidly (P < 0.05), followed by BCD. The ACD exhibited the numerically lowestmaximal rate of production and took thelongesttimeto reachit(P < 0.05). Acetate production followed the same basic trend as total SCFA production, with BCD exhibiting the greatest maximal acetate pro duction but with GCD having the numerically greatest maximal rateof acetate production and the shortesttime to attain it (P < 0.05). Again, ACD exhibited the low est maximal acetate productionand the lowest maximal rate of acetate production and took the longest time to reach it. Propionate production followed a very distinc tive profile, withACD resulting in the greatest maximal propionate production (P < 0.05), the greatest (numeri cal) maximal rate ofpropionate production, and the lon gest time to attain maximal rate ofproduction(P < 0.05). Butyrate production profiles also were unique, with GCD resulting in the greatest maximal butyrate produc tion (P < 0.05) and the numerically greatest maximal rateofproduction and with a time to attainmaximalrate of production intermediate to thoseofBCDand ACD.
Changes in pH after in vitro fermentation of ACD, BCD, and GCD are presentedin Table4. The pH was 6.9 for all cyclodextrins at the 0-h pull time. After 3 h offer mentation, both BCD and GCD exhibited a greater (P < 0.05) change in pH (-0.5) than ACD (-0.3). At the 6-h pull time, GCD had the greatest (P < 0.05) pH change (-1.8) followed by BCD (-1.4) and then ACD (-1.1). 'N/E = not estimable.
Changes in pH after fermentationfor 9 and 12 h were not differentamong treatmentsor betweenthese 2 pull times.
Apparent Heal and Total Tract Nutrient Digestibility
Body weight and BCS of dogs were not different among treatments (data not shown). Intake and digest ibilities by dogs of diets supplemented with ACD are presented in Table 5 . Average daily food intakes were similar among treatments throughout the study, with most of the dogs ingesting all the food they were pro vided. Heal digestibility of DM, OM, CP, and AHF were not different among treatments. On the contrary, total tract digestibilities of DM {P = 0.016), OM {P = 0.004), CP {P < 0.0001), and AHF (P = 0.001) exhib ited a linear decrease as ACD intake increased.
Heal DM concentration linearly increased (P = 0.008) as ACD intake increased. Fecal output ex pressed on an as-is basis (P < 0.0001), on a DM basis (P = 0.033), and on an as-is per gram DM intake basis linearly increased (P < 0.0001) with increasing ACD 'Change wasmeasured between pHat 0 h andpHat eachpulltime.
supplementation (Table 6 ). At the same time, fecal DM content linearly decreased (P = 0.001) and, con sequently, fecal scores linearly increased (P = 0.009). Fecal microbiota quantified by qPCR for dogs fed diets supplemented with ACD are presented in Table 7 . Bifidobacteria, C. perfringens^and E. coli were not dif ferent among treatments. Lactobacilli exhibited a qua dratic(P = 0.04) response to increasing ACD intake.
Serum cholesterol and TG concentrations and changes in concentration for dogs supplemented with ACD are shown in Table 8 . Serum cholesterol and TG concentrations were within normal ranges for dogs and were not different among treatments. Changes in concentration were not different from 0 (P > 0.05) and were similar among treatments.
DISCUSSION
Alpha-cyclodextrin is a fiber source suitable for human and companion animal nutrition. For this reason, this substrate and other cyclodextrin analogs were tested using human fecal inoculum to assess the fermentative profiles of these substrates in vitro and in vivo using the canine model to understand the im pact these substrates on ileal and total tract nutrient digestibility. Even though the domestic dog belongs to the order Camivora, it has an omnivore feeding be havior and shares similar gastrointestinal anatomy and physiology, dietary patterns, metabolic processes,and gastrointestinal diseases (Swanson and Schook, 2006; Swanson et al., 2011) . Therefore, a similar fermenta tive pattern between these species is expected.
Fermentation of ACD resulted in a unique SCFA pattern, with greater production of propionate than of acetate. In general, in vitro fermentation of different fiber sources yields acetate as the major end product, makingup 67% of total SCFA (Cummings, 1997) . This high production of propionate whenACD is fermented could partially explain the hypocholesterolemic effect observed in previous experiments as propionate can in hibit the enzyme 3-hydroxy-3-methyl-glutaryl-CoA reductase (Levrat et al., 1994) , the key regulatory enzyme Table 5 . Intake (g/d, as-fed basis) and apparent ileal and total tract nutrient digestibilities (%) by dogs fed diets supplemented with a-cyclodextrin (ACD) for endogenous cholesterol synthesis. Although ACD had the highest maximal rate ofpropionate production, the time to attain maximal production was greatest for ACD relative to BCD and CCD.
The less rigid structure of GCD favors its microbial fermentation (Oros et al., 1990) . Changes in pH and time to attain maximal production of total SCFA indicate that GCD is more readily fermented than BCD, which, in turn, is fermented faster than ACD. In general, pH decreased as fermentation time increased. However, there was no change in pH between the 9-and 12-h pull times. This lack of difference observed between these pull times indicates lack of further fer mentation because of the depletion of substrates and the potential buildup of waste products. Furthermore, the lack of difference in pH change among groups af ter 9 and 12 h of fermentation indicates that all sub strates were equally fermented at those pull times.
Comparative literature on this topic is scarce. Spears et al. (2007) evaluated the fermentation char acteristics of selected glucose-based polymers by ca nine and human fecal bacteria. Substrates included lyophilized canine ileal digesta containing maltodextrin, GCD, high-molecular-weight pullulan, and low-mo lecular-weight pullulan as dogs had been fed these test substances in another study. Maltodextrin-containing ileal digesta exhibited a higher butyrate and total SCFA production than did GCD-or pullulan-containing ileal digesta. However, there were no differences noted in time to attain maximal rate of production for acetate, propionate, or butyrate.
Apparent total tract digestibility quantifies the dif ference between amounts of nutrients consumed by the animal and those excreted in feces. However, feces contain a variable quantity ofsubstances ofnondietary origin (e.g., spent enzymes, gastrointestinal tract secretions, sloughed mucosal cells, and microbes). Therefore, to more accurately evaluate nutrient digest ibility, the ileal cannulated dog was used. This animal model has been used in several studies to evaluate il eal digestibility of diets containing a variety of carbo hydrate sources (Murray et al., 1998; Flickinger et al., 2000; Bednar et al., 2001; Spears et al., 2005) . Ileal digestibility coefficients for DM, OM, CP, and AHF were high and comparable with previous ly reported digestibility coefficients for diets with similar ingredient matrices (Middelbos et al., 2007; Faber et al., 2011) . Intake of ACD did not alter ileal nutrient digestibility. Other studies have reported nu trient digestibility unaltered by ACD intake. Artiss et al. (2006) studied the effects ofACD on weight reduc tion and blood lipids in rats. Rats were divided into 4 groups and fed ad libitum, for a period of 6 wk, a low-fat (4% fat) diet, a low-fat + ACD (0.4%) diet, a high-fat (40% fat) diet, and a high-fat + ACD (4%)
diet Intake ofACD did not alter fecal excretion of fat between the low-fat diets (0.16 g) or between the highfat diets (0.29 g). Spears et al. (2005) evaluated the effect ofCCD on ileal digestibility ofDM, OM, or CP, but fat digestibility was reduced 2% by CCD at a 25% dietaiy inclusion rate (approximately 120 g/d).
Total tract digestibility of all nutrients linearly de creased, even though there was no difference in ileal nutrient digestibility. Differences between the ileum and feces represent the contribution of the large bow el to total tract nutrient digestibility. Because dietary protein and fat are scarcely absorbed by the large in testine (Nordgaard and Mortensen, 1995) , differences between apparent ileal and total tract nutrient digest ibilities can be explained by modifications caused by microbes in the hindgut. Microbial biomass represents approximately 50% of feces (Cummings, 1997) , and microbial growth requires protein and fatty acids, which they can synthesize from carbon skeletons and NPN. Therefore, microbes are considered the primary source ofendogenous fat and protein excreted in feces. As previously reported, ACD is not degraded by hydrolytic-enzymatic digestion but is partially fermentable in the large intestine (Del Valle, 2004) . Fermentation ofACD may increase the synthesis ofendogenous fat and CP by microbes, which, in turn, will increase en dogenous losses offat and CP and reduce CP and AHF apparenttotal tract digestibilities (Kil et al., 2010) . At the same time, this reduction in CP and AHF apparent digestibility lowersDM and OM digestibility and thus increases fecal output. Another consequence of ACD fermentation is the production of SCFA, which influ ences fecal DM (Sunvold et al., 1995) . Short-chain fatty acids are rapidlyand almost completelyabsorbed by nonionic diffusion mechanisms but also by active transport mediated by a sodium-coupled transporter, thereby fostering the absorption of sodium and water (Roy et al., 2006) . However, because SCFAare weak anions, they may exert osmotic pressure in the colon and increase fecal water content (Roberfroid, 1993) , thus explaining the decrease in fecal DM and subse quent increase when ACD was supplemented.
Fermentability of ACD and its particular SCFA production profile might indicate possible changes in hindgut microbiota. Therefore, to screen for changes in microbiota, quantification by qPCR was used in this study. Dietary supplementation ofACD did not signif icant affect fecal bifidobacteria, E. coli, or C. perfringem. However, there was a quadratic effect of ACD intake on lactobacilli. This effect is evident by the decrease in lactobacilli for dogs receiving 6 g ACD, whereas there was an increase for those receiving 8 g.
Even though this effect reached statisticalsignificance, the biological significance of this effect is difficult to determine. However, it is important to note that what was quantified in this experiment was total cfu of the bacterial genera and species analyzed. Therefore, it Table8. Serum cholesterol and triglyceride concentrations andchanges in concentration for dogssupplemented with a-cyclodextrin (ACD)^a is possible that ACD might alter composition of microbial populations within those genera but not alter total cfu values. Future studies should be done using high-throughput sequencing technology to better un derstand the impact of cyclodextrins on the gastroin testinal microbiome ofdogs.
The lack of effect of ACD intake on serum cho lesterol concentrations is consistent with previous ex periments performed in our laboratory (Guevara et al., 2015) . It has been reported that the lack of cholesterol ester transfer protein activity in dogs results in high concentrations ofhigh-density lipoprotein cholesterol, which facilitates the redirection of cholesterol to the liver for clearance (Bailhache et al., 2004) . In summary, intake ofACD did not alter serum lipid concentrations or ileal nutrient digestibility values but resulted in a linear decrease in total tract nutrient digestibility, indicating active ACD fermentation in the large bowel. It is very likely that such fermentationpro duces a higher proportion ofpropionate as observed in the in vitro fermentation ofACD. Therefore, ACD sup plementation appears not to decrease nutrient absorp tion in the small intestine and its potential in modifying serum lipid profiles might be at least partially due to an altered fermentation in the large bowel. However, fur ther studies are warranted to elucidate the mechanism for the hypocholesterolemic effect ofACD; the use of obese and/or hyperlipidemic dogs might be a more re sponsive animal model for this purpose.
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